Non-invasive Parenteral Screening Instruments Market Insights, Global Outlook and Forecast 2022-2028
Non-invasive Parenteral Screening Instruments Market Insights, Global Outlook and Forecast 2022-2028
Analysis of the Non invasive Parenteral Screening Instruments Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.
The latest research study released by Market IntelliX evaluates market size and forecasts of Non-invasive Parenteral Screening Instruments in global, including the following market information:
Global Non-invasive Parenteral Screening Instruments Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Non-invasive Parenteral Screening Instruments Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Non-invasive Parenteral Screening Instruments companies in 2021 (%)
The global Non-invasive Parenteral Screening Instruments market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ultrasound Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-invasive Parenteral Screening Instruments include GE Healthcare, Philips, Illumina, Thermo Fisher Scientific, Roche, PacBio, Perkinelmer, Qiagen and Agilent Technologies and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Non-invasive Parenteral Screening Instruments manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Non-invasive Parenteral Screening Instruments Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-invasive Parenteral Screening Instruments Market Segment Percentages, by Type, 2021 (%)
Ultrasound Devices
Next-Generation Sequencing Systems
Polymerase Chain Reaction Instruments
Microarrays
Others
Global Non-invasive Parenteral Screening Instruments Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-invasive Parenteral Screening Instruments Market Segment Percentages, by Application, 2021 (%)
Diagnostic Laboratories
Hospitals
Global Non-invasive Parenteral Screening Instruments Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-invasive Parenteral Screening Instruments Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-invasive Parenteral Screening Instruments revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Non-invasive Parenteral Screening Instruments revenues share in global market, 2021 (%)
Key companies Non-invasive Parenteral Screening Instruments sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Non-invasive Parenteral Screening Instruments sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
GE Healthcare
Philips
Illumina
Thermo Fisher Scientific
Roche
PacBio
Perkinelmer
Qiagen
Agilent Technologies
BGI Group
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Non-invasive Parenteral Screening Instruments Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-invasive Parenteral Screening Instruments Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-invasive Parenteral Screening Instruments Overall Market Size
2.1 Global Non-invasive Parenteral Screening Instruments Market Size: 2021 VS 2028
2.2 Global Non-invasive Parenteral Screening Instruments Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Non-invasive Parenteral Screening Instruments Sales: 2017-2028
3 Company Landscape
3.1 Top Non-invasive Parenteral Screening Instruments Players in Global Market
3.2 Top Global Non-invasive Parenteral Screening Instruments Companies Ranked by Revenue
3.3 Global Non-invasive Parenteral Screening Instruments Revenue by Companies
3.4 Global Non-invasive Parenteral Screening Instruments Sales by Companies
3.5 Global Non-invasive Parenteral Screening Instruments Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Non-invasive Parenteral Screening Instruments Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Non-invasive Parenteral Screening Instruments Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-invasive Parenteral Screening Instruments Players in Global Market
3.8.1 List of Global Tier 1 Non-invasive Parenteral Screening Instruments Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-invasive Parenteral Screening Instruments Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-invasive Parenteral Screening Instruments Market Size Markets, 2021 & 2028
4.1.2 Ultrasound Devices
4.1.3 Next-Generation Sequencing Systems
4.1.4 Polymerase Chain Reaction Instruments
4.1.5 Microarrays
4.1.6 Others
4.2 By Type - Global Non-invasive Parenteral Screening Instruments Revenue & Forecasts
4.2.1 By Type - Global Non-invasive Parenteral Screening Instruments Revenue, 2017-2022
4.2.2 By Type - Global Non-invasive Parenteral Screening Instruments Revenue, 2023-2028
4.2.3 By Type - Global Non-invasive Parenteral Screening Instruments Revenue Market Share, 2017-2028
4.3 By Type - Global Non-invasive Parenteral Screening Instruments Sales & Forecasts
4.3.1 By Type - Global Non-invasive Parenteral Screening Instruments Sales, 2017-2022
4.3.2 By Type - Global Non-invasive Parenteral Screening Instruments Sales, 2023-2028
4.3.3 By Type - Global Non-invasive Parenteral Screening Instruments Sales Market Share, 2017-2028
4.4 By Type - Global Non-invasive Parenteral Screening Instruments Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Non-invasive Parenteral Screening Instruments Market Size, 2021 & 2028
5.1.2 Diagnostic Laboratories
5.1.3 Hospitals
5.2 By Application - Global Non-invasive Parenteral Screening Instruments Revenue & Forecasts
5.2.1 By Application - Global Non-invasive Parenteral Screening Instruments Revenue, 2017-2022
5.2.2 By Application - Global Non-invasive Parenteral Screening Instruments Revenue, 2023-2028
5.2.3 By Application - Global Non-invasive Parenteral Screening Instruments Revenue Market Share, 2017-2028
5.3 By Application - Global Non-invasive Parenteral Screening Instruments Sales & Forecasts
5.3.1 By Application - Global Non-invasive Parenteral Screening Instruments Sales, 2017-2022
5.3.2 By Application - Global Non-invasive Parenteral Screening Instruments Sales, 2023-2028
5.3.3 By Application - Global Non-invasive Parenteral Screening Instruments Sales Market Share, 2017-2028
5.4 By Application - Global Non-invasive Parenteral Screening Instruments Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Non-invasive Parenteral Screening Instruments Market Size, 2021 & 2028
6.2 By Region - Global Non-invasive Parenteral Screening Instruments Revenue & Forecasts
6.2.1 By Region - Global Non-invasive Parenteral Screening Instruments Revenue, 2017-2022
6.2.2 By Region - Global Non-invasive Parenteral Screening Instruments Revenue, 2023-2028
6.2.3 By Region - Global Non-invasive Parenteral Screening Instruments Revenue Market Share, 2017-2028
6.3 By Region - Global Non-invasive Parenteral Screening Instruments Sales & Forecasts
6.3.1 By Region - Global Non-invasive Parenteral Screening Instruments Sales, 2017-2022
6.3.2 By Region - Global Non-invasive Parenteral Screening Instruments Sales, 2023-2028
6.3.3 By Region - Global Non-invasive Parenteral Screening Instruments Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Non-invasive Parenteral Screening Instruments Revenue, 2017-2028
6.4.2 By Country - North America Non-invasive Parenteral Screening Instruments Sales, 2017-2028
6.4.3 US Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.4.4 Canada Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.4.5 Mexico Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Non-invasive Parenteral Screening Instruments Revenue, 2017-2028
6.5.2 By Country - Europe Non-invasive Parenteral Screening Instruments Sales, 2017-2028
6.5.3 Germany Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.5.4 France Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.5.5 U.K. Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.5.6 Italy Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.5.7 Russia Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.5.8 Nordic Countries Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.5.9 Benelux Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Non-invasive Parenteral Screening Instruments Revenue, 2017-2028
6.6.2 By Region - Asia Non-invasive Parenteral Screening Instruments Sales, 2017-2028
6.6.3 China Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.6.4 Japan Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.6.5 South Korea Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.6.6 Southeast Asia Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.6.7 India Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Non-invasive Parenteral Screening Instruments Revenue, 2017-2028
6.7.2 By Country - South America Non-invasive Parenteral Screening Instruments Sales, 2017-2028
6.7.3 Brazil Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.7.4 Argentina Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Non-invasive Parenteral Screening Instruments Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Non-invasive Parenteral Screening Instruments Sales, 2017-2028
6.8.3 Turkey Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.8.4 Israel Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.8.5 Saudi Arabia Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
6.8.6 UAE Non-invasive Parenteral Screening Instruments Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 GE Healthcare
7.1.1 GE Healthcare Corporate Summary
7.1.2 GE Healthcare Business Overview
7.1.3 GE Healthcare Non-invasive Parenteral Screening Instruments Major Product Offerings
7.1.4 GE Healthcare Non-invasive Parenteral Screening Instruments Sales and Revenue in Global (2017-2022)
7.1.5 GE Healthcare Key News
7.2 Philips
7.2.1 Philips Corporate Summary
7.2.2 Philips Business Overview
7.2.3 Philips Non-invasive Parenteral Screening Instruments Major Product Offerings
7.2.4 Philips Non-invasive Parenteral Screening Instruments Sales and Revenue in Global (2017-2022)
7.2.5 Philips Key News
7.3 Illumina
7.3.1 Illumina Corporate Summary
7.3.2 Illumina Business Overview
7.3.3 Illumina Non-invasive Parenteral Screening Instruments Major Product Offerings
7.3.4 Illumina Non-invasive Parenteral Screening Instruments Sales and Revenue in Global (2017-2022)
7.3.5 Illumina Key News
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Corporate Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Major Product Offerings
7.4.4 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Sales and Revenue in Global (2017-2022)
7.4.5 Thermo Fisher Scientific Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Non-invasive Parenteral Screening Instruments Major Product Offerings
7.5.4 Roche Non-invasive Parenteral Screening Instruments Sales and Revenue in Global (2017-2022)
7.5.5 Roche Key News
7.6 PacBio
7.6.1 PacBio Corporate Summary
7.6.2 PacBio Business Overview
7.6.3 PacBio Non-invasive Parenteral Screening Instruments Major Product Offerings
7.6.4 PacBio Non-invasive Parenteral Screening Instruments Sales and Revenue in Global (2017-2022)
7.6.5 PacBio Key News
7.7 Perkinelmer
7.7.1 Perkinelmer Corporate Summary
7.7.2 Perkinelmer Business Overview
7.7.3 Perkinelmer Non-invasive Parenteral Screening Instruments Major Product Offerings
7.7.4 Perkinelmer Non-invasive Parenteral Screening Instruments Sales and Revenue in Global (2017-2022)
7.7.5 Perkinelmer Key News
7.8 Qiagen
7.8.1 Qiagen Corporate Summary
7.8.2 Qiagen Business Overview
7.8.3 Qiagen Non-invasive Parenteral Screening Instruments Major Product Offerings
7.8.4 Qiagen Non-invasive Parenteral Screening Instruments Sales and Revenue in Global (2017-2022)
7.8.5 Qiagen Key News
7.9 Agilent Technologies
7.9.1 Agilent Technologies Corporate Summary
7.9.2 Agilent Technologies Business Overview
7.9.3 Agilent Technologies Non-invasive Parenteral Screening Instruments Major Product Offerings
7.9.4 Agilent Technologies Non-invasive Parenteral Screening Instruments Sales and Revenue in Global (2017-2022)
7.9.5 Agilent Technologies Key News
7.10 BGI Group
7.10.1 BGI Group Corporate Summary
7.10.2 BGI Group Business Overview
7.10.3 BGI Group Non-invasive Parenteral Screening Instruments Major Product Offerings
7.10.4 BGI Group Non-invasive Parenteral Screening Instruments Sales and Revenue in Global (2017-2022)
7.10.5 BGI Group Key News
8 Global Non-invasive Parenteral Screening Instruments Production Capacity, Analysis
8.1 Global Non-invasive Parenteral Screening Instruments Production Capacity, 2017-2028
8.2 Non-invasive Parenteral Screening Instruments Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-invasive Parenteral Screening Instruments Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-invasive Parenteral Screening Instruments Supply Chain Analysis
10.1 Non-invasive Parenteral Screening Instruments Industry Value Chain
10.2 Non-invasive Parenteral Screening Instruments Upstream Market
10.3 Non-invasive Parenteral Screening Instruments Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-invasive Parenteral Screening Instruments Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Non invasive Parenteral Screening Instruments Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|